Stablepoint Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Stablepoint Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Buy	5,139 +210	+4%	+$45.2K	0.18%	140
2026 Q1	$990K	Sell	4,929 -51	-1%	-$10.5K	0.15%	159
2025 Q4	$1.03M	Buy	4,980 +108	+2%	+$21.6K	0.16%	148
2025 Q3	$874K	Buy	4,872 +404	+9%	+$68.8K	0.14%	159
2025 Q2	$721K	Buy	4,468 +130	+3%	+$20.7K	0.12%	162
2025 Q1	$738K	Sell	4,338 -1,720	-28%	-$299K	0.13%	157
2024 Q4	$1.01M	Buy	6,058 +226	+4%	+$38.6K	0.18%	141
2024 Q3	$1M	Buy	5,832 +1,059	+22%	+$175K	0.18%	138
2024 Q2	$792K	Buy	4,773 +2,638	+124%	+$396K	0.15%	148
2024 Q1	$328K	Buy	2,135 +588	+38%	+$89.7K	0.07%	207
2023 Q4	$245K	Buy	+1,547	New	+$222K	0.06%	208

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Stablepoint Partners's FBT Position: Q2 2026 in Review

Stablepoint Partners increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 4.3% in Q2 2026, buying an estimated $45.2K and bringing the position to 5,139 shares worth $1.27M. The position accounts for 0.18% of the portfolio, ranked #140.

Stablepoint Partners first reported a position in FBT in Q4 2023 and has held it in 11 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Stablepoint Partners held 5,139 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.27M as of Q2 2026.
Stablepoint Partners bought 210 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $45.2K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.18% of Stablepoint Partners's portfolio in Q2 2026, its #140 holding.
Stablepoint Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 11 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.